OXALIPLATIN 5 mg/mL
oxaliplatin · INJECTION, SOLUTION, CONCENTRATE · Winthrop U.S, a business of sanofi-aventis U.S. LLC
No Recall History
Plain English
OXALIPLATIN is a injection, solution, concentrate containing oxaliplatin at 5 mg/mL, taken intravenous. Manufactured by Winthrop U.S, a business of sanofi-aventis U.S. LLC.
Key Facts
- Brand Name
- OXALIPLATIN
- Generic Name
- oxaliplatin
- NDC Code (Product)
0955-1731- Manufacturer
- Winthrop U.S, a business of sanofi-aventis U.S. LLC
- Strength
- 5 mg/mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA021759
- Drug Class
- Platinum-based Drug [EPC]
- Marketing Start
- 09/01/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is OXALIPLATIN used for?
OXALIPLATIN contains oxaliplatin. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is OXALIPLATIN a controlled substance?
OXALIPLATIN is not classified as a controlled substance by the DEA.
What is the generic name for OXALIPLATIN?
The generic name for OXALIPLATIN is oxaliplatin. There are 11 other brand versions of oxaliplatin.
What is the NDC code for OXALIPLATIN 5 mg/mL?
The NDC (National Drug Code) for OXALIPLATIN 5 mg/mL is 0955-1731, listed by Winthrop U.S, a business of sanofi-aventis U.S. LLC.